Research field (3)：
Tumor biology
, Experimental pathology
, Hematology and oncology
Research keywords (1)：
幹細胞 再生医学 Notch がん幹細胞
Research theme for competitive and other funds (22)：
2022 - 2025 The analysis of molecular pathogenesis of esophageal cancer from precancerous lesions showing clonal proliferation
2017 - 2021 Establishment of new target therapy depending on the origin of lung cancer stem cell
2014 - 2017 Establishment of new target therapy depending on the origin of lung cancer stem cell
2011 - 2013 The analysis of leukemia stem cell using iPS cell technology
2009 - 2011 Identification of gene targets for molecular diagnosis and therapeutics in hematopoietic malignancies based on advanced genomics
2008 - 2010 The role of Notch signaling in the leukemia stem cells.
2008 - 2010 造血器腫瘍における癌関連遺伝子の解析
2008 - 2009 Analysis of regulatory mechanism of hematopoiesis and exploration of the pathogenesis of hematopoietic neoplasms through comprehensive genetic analysis
2007 - 2008 Role of cell environmental signaling in the establishment of hematopoietic malignancies
2006 - 2007 Notchシグナル亢進による腫瘍化機構の解明
2006 - 2007 GENMOME-WIDEANALYSIS OF GENETIC BASIS OF HEMATOLOGICAL MALIGNANCIES
2006 - 2007 Functional analyses of the new tumor suppressor candidate gene in hematological malignancies
2006 - 2007 The role of Notch signaling in the regulation of hematopoietic stem cells in the niche
Kazuhiko Ishigaki, Keiki Kumano, Kyohei Fujita, Hiroo Ueno. Cellular basis of omentum activation and expansion revealed by single-cell RNA sequencing using a parabiosis model. Scientific Reports. 2021. 11. 1
Matsukawa, T, Yamamoto, T, Honda, A, Toya, T, Ishiura, H, Mitsui, J, Tanaka, M, Hao, A, Shinohara, A, Ogura, M, et al. Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy. Brain Communications. 2020. 2. 1. fcz048
Taoka K, Arai S, Kataoka K, Hosoi M, Miyauchi M, Yamazaki S, Honda A, Aixinjueluo W, Kobayashi T, Kumano K, et al. Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate. Scientific reports. 2018. 8. 1. 15855-15855
Patient-Derived Induced Pluripotent Stem Cells Identify ADAM8(CD156) as a NovelAntigen of TKI-resistant Chronic Myeloid Leukemia Cells.
(The 15th Stem Cell Research Symposium 2017)
Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 as a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells.
(58th American Society of Hematology (ASH) 2016)
Pre-HSCs derived from CML-iPSCs, as a platform of CML stem cells, reveal a novel marker of TKI-resistant CML cells.
(2016)
Pre-HSCs derived from CML-iPSCs represent a platform for analysis of TKI-resistant CMLstem cells.
(2016)
1995 - 1999 The University of Tokyo Graduate School of Medicine
1989 - 1993 The University of Tokyo Faculty of Medicine School of Medicine
Professional career (1)：
博士(医学) (東京大学)
Work history (6)：
2023/04 - 現在 Musashino University
2021/04 - 2023/03 International University of Health and Welfare
2013/04 - 2021/03 Kansai Medical University
2010/10 - 2013/03 東京大学 医学部 血液腫瘍病態学 講師
2008/10 - 2010/09 東京大学医学部附属病院 無菌治療部 特任講師
2007/04 - 2008/09 東京大学医学部付属病院 無菌治療部 助教
Show all
Committee career (3)：
日本再生医療学会 代議員
日本血液学会 評議員
日本癌学会 評議員
Awards (2)：
2004 - 日本血液学会奨励賞
2004 - 東京大学医師会賞
Association Membership(s) (11)：
日本免疫学会
, 日本分子生物学会
, 日本内科学会
, 日本再生医療学会
, 日本血液学会
, 日本癌学会
, 日本炎症・再生医学会
, 日本サイトメトリー学会
, 日本がん分子標的学会
, International Society of Stem Cell Research (ISSCR)
, American Society of Hematology
